Skip to main content
logo
Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.140
+0.010 (0.47%)
At close: Nov 6, 2026, 4:00 PM EST
2.300
+0.160 (7.48%)
After-hours: Nov 6, 2026, 5:36 PM EST

Edesa Biotech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
291714131498
Market Cap Growth
141.68%20.29%8.40%-6.42%-85.44%26.16%
Enterprise Value
1914127190
Last Close Price
2.132.474.454.426.4551.66

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-0.880.880.8856.67-
PB Ratio
51.431.407.291.891.527.49
P/TBV Ratio
-14.32-2.742.009.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
--0.010.010.000.01
Net Debt / Equity Ratio
-1.17-0.87-0.51-0.75-0.75-0.59
Net Debt / EBITDA Ratio
0.711.390.150.580.390.33
Net Debt / FCF Ratio
1.161.470.210.790.580.57
Quick Ratio
2.7010.600.713.293.907.64
Current Ratio
2.7610.680.913.534.258.29
Return on Equity (ROE)
-122.93%-99.57%-136.66%-101.88%-156.34%-120.39%
Return on Assets (ROA)
-66.43%-57.02%-69.02%-56.33%-87.78%-116.79%
Return on Capital Employed (ROCE)
-166.00%-63.50%-354.10%-130.50%-194.70%-180.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-80.93%-41.34%-42.70%-62.82%-123.19%-13.64%
FCF Yield
-30.38%-42.12%-33.84%-49.78%-86.24%-13.98%
Buyback Yield / Dilution
-72.33%-77.54%-11.84%-36.37%-21.50%-40.32%
SEC Filings: 10-K · 10-Q